Product Name: Human FceR2 / CD23 Antibody (Lumiliximab, Research Use)
Catalog Number: NBR-0679
Target Name: FceR2 / CD23
Trade Name: Lumiliximab
Antibody Drug Description: Lumiliximab is a primatized, IgG1, anti-CD23 mAb that was studied in PBMCs of atopic patients and shown to reduce allergen-induced PBMC proliferation and levels of proinflammatory cytokines such as IL-1β, IL-5, and TNF-α. Appearance: Transparent Liquid
Molecular Weight: ~150kDa
CAS：N/A
Solubility: Water; PBS, TBS Buffer etc.
Expression System: CHO Expressed
Isotype of Ab: Ab. Isotype - IgG

  Gene Name: FCER2
Synonyms: CLEC4J; CD23; FCE2
Target Description: Low-affinity receptor for immunoglobulin E (IgE) and CR2/CD21. Has essential roles in the regulation of IgE production and in the differentiation of B-cells (it is a B-cell-specific antigen).
Ensembl: ENSG00000104921
Uniprot: P06734